Clinical Trial Update: A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial to evaluate the effects of inclisiran on clinical outcomes in people with atherosclerotic cardiovascular disease; currently ACTIVE_NO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease

Drugs mentioned

• Inclisiran (inclisiran)

Snippet

Sponsor: University of Oxford | Conditions: Atherosclerotic Cardiovascular Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING